EnteroMedics Inc. (ETRM) is a medical technology company that focuses on treating obesity, metabolic diseases, and other gastrointestinal disorders. The company's main product, vBloc Therapy, is a device that is designed to help patients lose weight by interrupting hunger signals between the brain and the stomach. The vBloc Therapy device is implanted during a minimally invasive surgical procedure and uses high-frequency electrical pulses to block hunger signals.
EnteroMedics was founded in 2002 and is headquartered in St. Paul, Minnesota. The company's shares are traded on the OTC Pink Market under the symbol ETRM.
As of the latest available information, EnteroMedics had a market capitalization of approximately $5.5 million. However, it should be noted that companies listed on the OTC Pink Market are often subject to low liquidity and may be highly volatile. Investors should carefully consider the risks associated with investing in such companies before making any investment decisions.
EnteroMedics Inc. (ETRM) is a medical technology company that focuses on treating obesity, metabolic diseases, and other gastrointestinal disorders. The company's main product, vBloc Therapy, is a device that is designed to help patients lose weight by interrupting hunger signals between the brain and the stomach. The vBloc Therapy device is implanted during a minimally invasive surgical procedure and uses high-frequency electrical pulses to block hunger signals.